JBM  Vol.7 No.11 , November 2019
Study on the Grouping of Patients with Chronic Infectious Diseases Based on Data Mining
Min Li1,2
Objective: According to RFM model theory of customer relationship management, data mining technology was used to group the chronic infectious disease patients to explore the effect of customer segmentation on the management of patients with different characteristics. Methods: 170,246 outpatient data was extracted from the hospital management information system (HIS) during January 2016 to July 2016, 43,448 data was formed after the data cleaning. K-Means clustering algorithm was used to classify patients with chronic infectious diseases, and then C5.0 decision tree algorithm was used to predict the situation of patients with chronic infectious diseases. Results: Male patients accounted for 58.7%, patients living in Shanghai accounted for 85.6%. The average age of patients is 45.88 years old, the high incidence age is 25 to 65 years old. Patients was gathered into three categories: 1) Clusters 1—Important patients (4786 people, 11.72%, R = 2.89, F = 11.72, M = 84,302.95); 2) Clustering 2—Major patients (23,103, 53.2%, R = 5.22, F = 3.45, M = 9146.39); 3) Cluster 3—Potential patients (15,559 people, 35.8%, R = 19.77, F = 1.55, M = 1739.09). C5.0 decision tree algorithm was used to predict the treatment situation of patients with chronic infectious diseases, the final treatment time (weeks) is an important predictor, the accuracy rate is 99.94% verified by the confusion model. Conclusion: Medical institutions should strengthen the adherence education for patients with chronic infectious diseases, establish the chronic infectious diseases and customer relationship management database, take the initiative to help them improve treatment adherence. Chinese governments at all levels should speed up the construction of hospital information, establish the chronic infectious disease database, strengthen the blocking of mother-to-child transmission, to effectively curb chronic infectious diseases, reduce disease burden and mortality.
Cite this paper: Li, M. (2019) Study on the Grouping of Patients with Chronic Infectious Diseases Based on Data Mining. Journal of Biosciences and Medicines, 7, 119-135. doi: 10.4236/jbm.2019.711011.

[1]   Sung, S.F., Hsieh, C.Y., Kao Yang, Y.H., Lin, H.J., Chen, C.H., Chen, Y.W. and Hu, Y.H. (2015) Developing a Stroke Severity Index Based on Administrative Data Was Feasible Using Data Mining Techniques. J Clin Epidemiol, 68, 1292-1300.

[2]   Leary, A., Cook, R., Jones, S., Smith, J., Gough, M., Maxwell, E., Punshon, G. and Radford, M. (2016) Mining Routinely Collected Acute Data to Reveal Non-Linear Relationships between Nurse Staffing Levels and Outcomes. BMJ Open, 6, e011177.

[3]   Teufel, A. (2015) Bioinformatics and Database Resources in Hepatology. J Hepatol, 62, 712-719.

[4]   Cao, B., Kong, X., Kettering, C., Yu, P. and Ragin, A. (2015) Determinants of HIV-Induced Brain Changes in Three Different Periods of the Early Clinical Course: A Data Mining Analysis. Neuroimage Clin, 9, 75-82.

[5]   Zare Hosseini, Z. and Mohammadzadeh, M. (2016) Knowledge Discovery from Patients’ Behavior via Clustering-Classification Algorithms Based on Weighted eRFM and CLV Model: An Empirical Study in Public Health Care Services. Iran J Pharm Res, 15, 355-367.

[6]   Lee, E.W. (2012) Data Mining Application in Customer Relationship Management for Hospital Inpatients. Healthc Inform Res, 18, 178-185.

[7]   Kondasani, R.K. and Panda, R.K. (2015) Customer Perceived Service Quality, Satisfaction and Loyalty in Indian Private Health Care. Int J Health Care Qual Assur, 28, 452-467.

[8]   Poku, M.K., Behkami, N.A. and Bates, D.W. (2017) Patient Relationship Management: What the U.S. Healthcare System Can Learn from Other Industries. J Gen Intern Med., 32, 101-104.

[9]   Walker, D.D., van Jaarsveld, D.D. and Skarlicki, D.P. (2017) Sticks and Stones Can Break My Bones but Words Can Also Hurt Me: The Relationship between Customer Verbal Aggression and Employee Incivility. J Appl Psychol, 102, 163-179.

[10]   Orenga-Roglá, S. and Chalmeta, R. (2016) Springer plus Social Customer Relationship Management: Taking Advantage of Web 2.0 and Big Data Technologies. Springerplus, 5, 1462-1478.

[11]   Chen, Y.S., Cheng, C.H., Lai, C.J., Hsu, C.Y. and Syu, H.J. (2012) Identifying Patients in Target Customer Segments Using a Two-Stage Clustering-Classification Approach: A Hospital-Based Assessment. Comput Biol Med., 42, 213-221.

[12]   Cubillas, J.J., Ramos, M.I., Feito, F.R., González, J.M., Gersol, R. and Ramos, M.B. (2015) Importance of Health CRM in Pandemics and Health Alerts. Aten Primaria, 47, 267-272.

[13]   Quero, M., Ramos, M.B., López, W., Cubillas, J.J., González, J.M. and Castillo, J.L. (2016) Use of Customer Relationship Management to Improve Healthcare for Citizens. The 24h Andalusian Health Service: Health line. Gac Sanit, 30, 397-400.

[14]   Kardas, P., Lewek, P. and Matyjaszczyk, M. (2013) Determinants of Patient Adherence: A Review of Systematic Reviews. Front Pharmacol, 25, 91-106.

[15]   Bright, C.E. (2017) Measuring Medication Adherence in Patients With Schizophrenia: An Integrative Review. Arch Psychiatr Nurs, 31, 99-110.

[16]   Lo-Ciganic, W.H., Donohue, J.M., Jones, B.L., Perera, S., Thorpe, J.M., Thorpe, C.T., Marcum, Z.A. and Gellad, W.F. (2016) Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program. J Gen Intern Med, 31, 1052-1060.

[17]   Lönnroth, K., Castro, G.K., Chakaya, J.M., Chauhan, L.S., Floy, K., Glaziou, P. and Raviglione, M.C. (2010) Tuberculosis Control and Elimination 2010-50: Cure, Care, and Social Development. Lancet, 375, 1755-1757.

[18]   Cremers, A.L., Gerrets, R., Kapata, N., Kabika, A., Birnie, E., Klipstein-Grobusch, K. and Grobusch, M.P. (2016) Tuberculosis Patients’ Pre-Hospital Delay and Non-Adherence with a Longstanding DOT Programme: A Mixed Methods Study in Urban Zambia. BMC Public Health, 16, 1130.

[19]   Lei, X., Huang, K., Liu, Q., Jie, Y.F. and Tang, S.L. (2016) Are Tuberculosis Patients Adherent to Prescribed Treatments in China? Results of a Prospective Cohort Study. Infect Dis Poverty, 5, 38.

[20]   Song, Z.L., Cui, Y.J., Zheng, W.P., Teng, D.H. and Zheng, H. (2015) Application of Nucleoside Analogues to Liver Transplant Recipients with Hepatitis B. World J Gastroenterol, 21, 12091-12100.

[21]   Hegde, S.K., Fathima, F.N., Agrawal, T. and Misquith, D. (2016) Adherence to Prescribed Medications for Chronic Illnesses among Older Adults in a Rural Community, Karnataka, India. Geriatr Gerontol Int, 16, 1339-1345.

[22]   Wójcik, K., Piekarska, A. and Jablonowska, E. (2016) Adherence to Antiviral Therapy in HIV or HBV-Infected Patients. Przegl Epidemiol, 70, 27-32, 115-118.

[23]   Petersen, T., Townsend, K., Gordon, L.A., Sidharthan, S., Silk, R., Nelson, A., Gross, C., Calderón, M., Proschan, M., Osinusi, A., Polis, M.A., Masur, H., Kottilil, S. and Kohli, A. (2016) High Adherence to All-Oral Directly Acting Antiviral HCV Therapy among an Inner-City Patient Population in a Phase 2a Study. Hepatol Int, 10, 310-319.

[24]   Wang, W., Liu, W., Chen, T., Liu, N.P., Zheng, Y.J., Ye, S.D., Zhang, Y., Wang, X.M., Wang, G.Z. and Zhang, H.B. (2017) Factors Influencing Antiretroviral Therapy Adherence among HIV-Infected People on Antiretroviral Therapy in Ili Kazakh Autonomous Prefecture. Zhonghua Yu Fang Yi XueZa Zhi, 51, 160-164.

[25]   Unger, N.R., Worley, M.V., Kisgen, J.J., Sherman, E.M. and Childs-Kean, L.M. (2016) Elvitegravir for the Treatment of HIV. Expert Opin Pharmacother, 17, 2359-2370.

[26]   Qin, Q., Guo, W., Tang, W., Mahapatra, T., Wang, L., Zhang, N., Ding, Z., Cai, C., Cui, Y. and Sun, J. (2017) Spatial Analysis of the Human Immunodeficiency Virus Epidemic among Men Who Have Sex with Men in China, 2006-2015. Clin Infect Dis, 64, 956-963.

[27]   Yan, J., Liu, J., Su, B., Pan, X., Wang, Z., Wu, J., Zhang, J., Ruan, Y., His, J., Liao, L., Shao, Y. and Xing, H. (2016) Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China. PLoS One, 11, e0154421.

[28]   Xie, N., Xu, J., Yao, Z., Zhou, W. and Wang, X. (2016) Mode of Antiretroviral Treatment Based on the Medical Needs of People Living with HIV/AIDS. Zhonghua Liu Xing Bing Xue Za Zhi, 37, 539-542.

[29]   Egelund, E.F., Dupree, L., Huesgen, E. and Peloquin, C.A. (2017) The Pharmacological Challenges of Treating Tuberculosis and HIV Coinfections. Expert Rev Clin Pharmacol, 10, 213-223.

[30]   Bandera, A., Colella, E., Rizzardini, G., Gori, A. and Clerici, M. (2017) Strategies to Limit Immune-Activation in HIV Patients. Expert Rev Anti Infect Ther, 15, 43-54.

[31]   Palma, A.M., Rabkin, M., Nuwagaba-Biribonwoha, H., Bongomin, P., Lukhele, N., Dlamini, X., Kidane, A. and El-Sadr, W.M. (2016) Can the Success of HIV Scale-Up Advance the Global Chronic NCD Agenda? Glob Heart, 11, 403-408.

[32]   Escolano, A., Dosenovic, P. and Nussenzweig, M.C. (2017) Progress toward Active or Passive HIV-1 Vaccination. J Exp Med, 214, 3-16.

[33]   Chaisson, L.H., Saraceni, V., Cohn, S., Seabrook, D., Cavalcante, S., Chaisson, R.E., Golub, J. and Durovni, B. (2019) CD4 Count Stratification to Guide Tuberculosis Preventive Therapy for People Living with HIV. AIDS.

[34]   Kagujje, M., Mubiana, M.L., Mwamba, E. and Muyoyeta, M. (2019) Implementation of Isoniazid Preventive Therapy in People Living with HIV in Zambia: Challenges and Lessons. BMC Public Health, 19, 1329.

[35]   Shah, M., Risher, K., Berry, S.A. and Dowdy, D.W. (2016) The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States. Clin Infect Dis, 62, 220-229.

[36]   Fang, Q., Hao, Y.H., Li, L., Zhang, Z.H., Wang, J.Z., Chen, M.F., Kang, J. and Yang, D.L. (2013) Chronic HBV Carrier’s Acceptance of Regular Surveilling Program in China. JHuazhong UnivSci Technolog Med Sci, 33, 288-292.

[37]   Sun, W.-C., Hsu, P.-I., Yu, H.-C., , Lin, K.-H. Tsay, F.-W., Wang, H.-M., Tsai, T.-J., Chen, W.-C., Lai, K.-H. and Cheng, J.-S. (2015) The Adherence of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System. PLoS One, 10, 1-16.

[38]   Ford, N., Matteelli, A., Shubber, Z., Hermans, S., Meintjes, G., Grinsztejn, B., Waldrop, G., Kranzer, K., Doherty, M. and Getahun, H. (2016) TB as a Cause of Hospitalization and In-Hospital Mortality among People Living with HIV Worldwide: A Systematic Review and Meta-Analysis. J Int AIDS Soc, 19, 20714.

[39]   Klein, C.G., Cicinnati, V., Schmidt, H., Ganten, T., Scherer, M.N., Braun, F., Zeuzem, S., Wartenberg-Demand, A., Niemann, G., Schmeidl, R. and Beckebaum, S. (2013) Adherence and Tolerability of Subcutaneous Hepatitis B Immunoglobulin Self-Administration in Liver Transplant Patients: A Prospective, Observational, Multicenter Study. Ann Transplant, 13, 677-684.

[40]   Terasaki, J., Singh, G., Zhang, W., Wagner, P. and Sharma, G. (2015) Using EMR to Improve Adherence with Clinical Practice Guidelines for Management of Stable COPD. Respir Med, 109, 1423-1429.

[41]   Zhang, S., Ma, Q., Liang, S., Xiao, H., Zhuang, G., Zou, Y., Tan, H., Liu, J., Zhang, Y., Zhang, L., Feng, X., Xue, L., Hu, D., Cui, F. and Liang, X. (2016) Annual Economic Burden of Hepatitis B Virus-Related Diseases among Hospitalized Patients in Twelve Cities in China. J Viral Hepat, 23, 202-210.

[42]   Xiao, J., Lin, H., Liu, T., Zeng, W., Li, X., Shao, X., Tan, Q., Xu, Y., Xu, X., Zheng, H. and Ma, W. (2015) Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China. Int J Environ Res Public Health, 12, 14055-14067.

[43]   Che, Y.H., Chongsuvivatwong, V., Li, L., Sriplung, H., Wang, Y.Y., You, J., Ma, S.J., Yan, Y., Zhang, R.Y., Shen, T., Chen, H.M., Rao, S.F. and Zhang, X.L. (2016) Financial Burden on the Families of Pa-tients with Hepatitis B Virus-Related Liver Diseases and the Role of Public Health Insurance in Yunnan Province of China. Public Health, 130, 13-20.

[44]   Hutchison, C., Khan, M.S., Yoong, J., Lin, X. and Coker, R.J. (2017) Financial Barriers and Coping Strategies: A Qualitative Study of Accessing Multidrug-Resistant Tuberculosis and Tuberculosis Care in Yunnan, China. BMC Public Health, 17, 221.

[45]   Are, C., Meyer, B., Stack, A., Ahmad, H., Smith, L., Qian, B., Song, T. and Chowdhury, S. (2017) Global Trends in the Burden of Liver Cancer. J Surg Oncol, 115, 591.

[46]   Ding, P., Li, X., Jia, Z. and Lu, Z. (2017) Multidrug-Resistant Tuberculosis (MDR-TB) Disease Burden in China: A Systematic Review and Spatio-Temporal Analysis. BMC Infect Dis, 17, 57.

[47]   Gish, R.G., Yuen, M.F., Chan, H.L., Given, B.D., Lai, C.L., Locarnini, S.A., Lau, J.Y., Wooddell, C.I., Schluep, T. and Lewis, D.L. (2015) Synthetic RNAi Triggers and Their Use in Chronic Hepatitis B Therapies with Curative Intent. Antiviral Res, 121, 97-108.

[48]   Joshi, R.K. and Mehendale, S.M. (2016) Can We Replace HIV Sentinel Surveillance Platform with Prevention of Parent-to-Child Transmission (PPTCT) Program Data to Assess HIV Burden and Trends in India? Trans R Soc Trop Med Hyg, 110, 393-399.

[49]   Yotebieng, M., Thirumurthy, H., Moracco, K.E, Kawende, B., Chalachala, J.L., Wenzi, L.K., Ravelomanana, N.L., Edmonds, A., Thompson, D., Okitolonda, E.W. and Behets, F. (2016) Conditional Cash Transfers and Uptake of and Retention in Prevention of Mother-to-Child HIV Transmission Care: A Randomised Controlled Trial. Lancet HIV, 3, e85-93.

[50]   Ilboudo, D., Simpore, J., Ouermi, D., Bisseye, C., Sagna, T., Odolini, S., Buelli, F., Pietra, V., Pignatelli, S., Gnoula, C., Nikiema, J.B. and Musumeci, S. (2010) Towards the Complete Eradication of Mother-to-Child HIV/HBV Coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Braz J Infect Dis, 14, 219-224.